Top > Biopharmaceuticals > Research and Development
Member Reviews
Visitor Ratings 
Google PR 
Member Reviews Visitor Ratings Google PR 
Member Reviews Visitor Ratings Google PR 
Member Reviews Visitor Ratings Google PR 
Member Reviews Visitor Ratings Google PR 
Member Reviews Visitor Ratings Google PR 
Member Reviews Visitor Ratings Google PR 
Web Links
Research and Development
Emerging drug development company focused on the clinical development and regulatory approval of neuroscience drugs. Includes news and product and investor information.
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Discovers, develops, manufactures and markets products for the treatment of psychiatric and neurological disorders such as obesity and other eating disorders, anxiety, schizophrenia, sleep disorders, cognitive impairment, depression, epilepsy and stress disorders. (Nasdaq: NRGN).
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
For detailed information visit the website, please...
waiting for hand_moderation
waiting for hand_moderation
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR 33. Sequenom, Inc.
Researches and develops high definition dna analysis tools for industrial biomedical and life science applications. (Nasdaq: SQNM).
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
For detailed information visit the website, please...
waiting for hand_moderation
waiting for hand_moderation
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Developer of anti-arthritis drug CF101 presents its management, technology, and research pipeline. Includes a list of publications and patents.
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
is an Israeli biopharmaceutical company with fully integrated pharmaceutical
discovery and clinical development capabilities. The company has
diverse pipeline of proprietary compounds that address inflammatory,
ophthalmic and liver diseases.
utilizes the Gi protein associated A 3
adenosine
For detailed information visit the website, please...
For detailed information visit the website, please...
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR 35. Trimeris, Inc.
Discovers and develops novel therapeutic agents which block viral infection by inhibiting viral fusion with host cells, as in anti-HIV therapy. Includes overview of projects, investment data, and profile of company in Durham, North Carolina. (Nasdaq: TRMS)
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Trimeris, Inc., biopharmaceutical company focused on the treatment of viral diseases
FUZEON ® is the first in a class of anti-HIV drugs called fusion inhibitors. Learn more about the only FDA-approved fusion inhibitor... ©2008 Trimeris, Inc., Durham, North Carolina, US FUZEON is the first in a class of anti-HIV drugs called fusion inhibitors. The Leadership Behind
FUZEON ® is the first in a class of anti-HIV drugs called fusion inhibitors. Learn more about the only FDA-approved fusion inhibitor... ©2008 Trimeris, Inc., Durham, North Carolina, US FUZEON is the first in a class of anti-HIV drugs called fusion inhibitors. The Leadership Behind
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR 36. Scios, Inc.
Discovers, develops and commercializes novel human therapeutics focusing in the areas of cardiopulmonary diseases, renal and metabolic disorders, tissue repair and other chronic diseases. Profile of company in Mountain View, California. (Nasdaq: SCIO)
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
For detailed information visit the website, please...
waiting for hand_moderation
waiting for hand_moderation
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Develops and commercializes vaccines, and novel antiviral therapeutics for category A pathogens, infectious diseases, and potential bio-defense. Laboratories in Corvallis, Oregon, headquartered in New York City. (Nasdaq: SIGA)
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
SIGA Human BioArmor - Smallpox drug and vaccine development to aid in preventing and treating Smallpox. SIGA is a leader in Smallpox Antiviral vaccines and development for infectious disease.
SIGA APPOINTS WILLIAM C. BEVINS AND FRANCES FRAGOS TOWNSEND TO New York, New York, March 14, 2011 -- SIGA Technologies, Inc. (NASDAQ: SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today that William C. Bevins and Frances
SIGA APPOINTS WILLIAM C. BEVINS AND FRANCES FRAGOS TOWNSEND TO New York, New York, March 14, 2011 -- SIGA Technologies, Inc. (NASDAQ: SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today that William C. Bevins and Frances
Date Added: Apr 2, 2011 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Pages: [< Previous] 1 2 3 4
Main Category
14
100
31
5
50
7
11
40
166
20
59
76
24
75
110
142
7
8
13
30
66
Join Mailing List
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.
Top 10
Directory Statistics
Links: 1054
Categories: 36
Pagerank Statistics
Yahoo News